Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cardiovascular Drug Reviews|July 9, 2003
Bucillamine: a potent thiol donor with multiple clinical applicationsLawrence D Horwitz
Cancer Investigation|December 27, 2005
Cell permeable iron chelators as potential cancer chemotherapeutic agentsPaula M B Pahl, Lawrence D Horwitz
Biochemical and Biophysical Research Communications|February 21, 2004
Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelinsYvonne K Hodges, William E Antholine, Lawrence D Horwitz
Journal of Experimental Therapeutics & Oncology|June 8, 2007
A lipid-soluble iron chelator alters cell cycle regulatory protein binding in breast cancer cells compared to normal breast cellsPaula M B Pahl, Sara M Reese, Lawrence D Horwitz
American Journal of Physiology. Heart and Circulatory Physiology|July 12, 2005
Regulation of oxygen delivery during induced polycythemia in exercising dogsJoAnn Lindenfeld, John V Weil, Victoria L Travis, et al.
Journal of Cardiovascular Pharmacology|May 18, 2005
Paradoxical effects of iron chelation on growth of vascular endothelial cellsYvonne K Hodges, Sara M Reese, Paula M B Pahl, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 8, 2006
Desferri-Exochelin, a lipid-soluble, hexadentate iron chelator, effectively removes tissue ironYvonne K Hodges, Howard D Weinberger, Janet Stephens, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 12, 2008
Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in miceS Kelly Ambler, Yvonne K Hodges, Gayle M Jones, et al.
Pageof 2